We are pleased to congratulate Simon Mølgaard, CEO of Teitur Trophics, on receiving the Rising Star Award at this year’s Biotech Spring Gala.

The award, presented by DANISH BIO – Dansk Biotek, recognizes emerging leaders who are making a significant impact within the biotech industry. The recognition reflects Simon’s strong leadership and the impressive progress Teitur Trophics continues to make in advancing innovative therapies for neurodegenerative diseases.

At Sound Bioventures, we are proud to support Teitur Trophics as part of our portfolio and to follow the company’s continued development. The award is also a testament to the dedication and scientific excellence of the entire Teitur team, whose work is driven by a shared ambition to develop meaningful new treatment options for patients living with Parkinson’s disease.

Teitur Trophics is entering an exciting phase, with Phase 1 readout data in Parkinson’s disease patients expected in June, followed by participation at BIO International later this month.

We congratulate Simon and the entire Teitur Trophics team on this well-deserved recognition and look forward to following the company’s continued progress.